Different Types of Wounds

  • Vibhakar Vachhrajani
  • Payal Khakhkhar


There are many different types of wounds which we come across in our day to day practice. We need to take biopsy in so many patients. There are some medicines responsible for ulcers, some autoimmune conditions and some systemic diseases associated with skin ulcerations. In some ulcers it is difficult to know why they are not healing and sometimes out of many local wound dressing materials, some dressing material works wonders. These rare types of skin ulcers need expertise to diagnose and treat.


  1. 1.
    Settle JAD, editor. Principles and practice of burn management. New York: Churchill Livingstone; 1996.Google Scholar
  2. 2.
    Babu M, Shanmuganathan N, Karthikeya Prabhu B. In: Surabahi S, Tiwari VK, Goel A, editors. Wound healing in burns from principles and practice of burn care. New Delhi: Jaypee Brothers Medical Publishers; 2010. p. 51–68.CrossRefGoogle Scholar
  3. 3.
    Zawaki BE. In: Boswick Jr JA, editor. The local effects of burn injury. The art and science of burn care. Rockville: Aspen; 1987. p. 27.Google Scholar
  4. 4.
    Zawaki BE. Reversal of capillary stasis and prevention of necrosis in burns. Ann Surg. 1974b;139:98.CrossRefGoogle Scholar
  5. 5.
    Sarabahi S. In: Sarabahi S, Yiwari VK, Goel A, editors. Burn wound management from principle and practice of burn care. New Delhi: Jaypee publishers; 2010. p. 153–95.Google Scholar
  6. 6.
    Editorial. Management of smelly tumours. Lancet. 1990;1:141–2.Google Scholar
  7. 7.
    Moody M, Grocott P. Let us extend our knowledge base. Assessment and management of fungating malignant wounds. Prof Nurse. 1993;8(9):587–90.Google Scholar
  8. 8.
    Fairburn K. Towards better care for women. Understanding fungating breast lesions. Prof Nurse. 1993;8(12):204–12.Google Scholar
  9. 9.
    Haisfield-Wolfe ME, Rund C. Malignant cutaneous wounds: a management protocol. Ostomy Wound Manage. 1997;43:56–66.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Naylor W. Malignant wounds: etiology and principles of management. Nurs Stand. 2002;16:45–53.CrossRefGoogle Scholar
  11. 11.
    Bird C. Managing malignant fungating wounds. Prof Nurse. 2006;15(4):253–6.Google Scholar
  12. 12.
    Landthaler M, Hagspiel HJ, Braun-falco O. Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumours. Arch Dermatol. 1995;131(2):182–6.CrossRefGoogle Scholar
  13. 13.
    Borg M, Wilkinson D, Humeniuk V, Norman J. Successful treatment of radiation induced breast ulcer with hyperbaric oxygen. Breast. 2001;10(4):336–41.CrossRefGoogle Scholar
  14. 14.
    Goel A. Chapter 24: Pressure sores. In: Principle and practice of wound care; 2012. p. 293–5.Google Scholar
  15. 15.
    Assmann G, Pfreunds Chuh M, Voswinkel J. Rituximab in patients with rheumatoid arthritis and vasculitis associated cutaneous ulcers. Clin Exp Rheumatol. 2010;28(57):81–3.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Lui NL, Thumboo J, Fong KY. A case of refractory vasculitis ulcer in systemic lupus erythematous patients responding to rituximab and hyperbaric oxygen therapy. Int J Rheum Dis. 2009;12(4):366–9.CrossRefGoogle Scholar
  17. 17.
    Veale DJ, Muir AH, Morley KD, JJF B. Treatment of vasculitic leg ulcers in connective tissue disease with iloprost. Clin Rheumatol. 1995;14(2):187–90.CrossRefGoogle Scholar
  18. 18.
    Kato N, Kimura K, Yasukawa K, Yoshida K. Hydroxyurea-related leg ulcers in a patient with chronic myelogenous leukemia: a case report and review of the literature. J Dermatol. 1999;26:56–62.CrossRefGoogle Scholar
  19. 19.
    Suehiro M, Kishimoto S, Wakabayashi T, Ikeuchi A, Miyake H, Takenaka H, Okano A, Hirai H, Shimazaki C, Yasuno H. Hydroxyurea dermopathy with a dermatomyositis-like eruption and a large leg ulcer. Br J Dermatol. 1998;139:748–9.CrossRefGoogle Scholar
  20. 20.
    Best PJ, Daoud MS, Pittelkow MR, Petitt RM. Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med. 1998;128:29–32.CrossRefGoogle Scholar
  21. 21.
    Ghorpade A. Lupus vulgaris over a tattoo mark--inoculation tuberculosis. J Eur Acad Dermatol Venereol. 2003;17(5):569–71. PMID 12941097.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    James WD, Berger TG, et al. Andrews’ diseases of the skin: clinical dermatology. New York: Saunders Elsevier; 2006. p. 335. isbn:978-0-7216-2921-6.Google Scholar
  23. 23.
    Matta N, Abbas O, Maakaron JE, Koussa S, Daderian RH, Taher AT. Leg ulcers in patients with β-thalassaemia intermedia: a single centre's experience. J Eur Acad Dermatol Venereol. 2013;28(9):1245–50. Scholar
  24. 24.
    Eckman JR. Leg ulcers in sickle cell disease. Hematol Oncol Clin North Am. 1996;10:1333. CrossRefPubMedWeb of ScienceGoogle Scholar.CrossRefGoogle Scholar
  25. 25.
    Quimby SR, Muller SA, Schroeter AL. The cutaneous immunopathology of necrobiosis lipoidica diabeticorum. Arch Dermatol. 1988;124(9):1364–71. [PubMed].CrossRefGoogle Scholar
  26. 26.
    Gebauer K, Armstrong M. Koebner phenomenon with necrobiosis lipoidica diabeticorum. Int J Dermatol. 1993;32(12):895–6.CrossRefGoogle Scholar
  27. 27.
    Hashemi DA, Brown-Joel ZO, Tkachenko E, Nelson CA, Noe MH, Imadojemu S, Vleugels RA, Mostaghimi A, Wanat KA, Rosenbach M. Clinical features and comorbidities of patients with necrobiosis lipoidica with or without diabetes. JAMA Dermatol. 2019;155(4):455–9.CrossRefGoogle Scholar
  28. 28.
    Bascom JU. Pilonidal disease: long-term results of follicle removal. Dis Colon Rectum. 1983;23:800–7. Scholar
  29. 29.
    Bascom JU. Repeat pilonidal operations. Am J Surg. 1987;154(1):118–22. Scholar
  30. 30.
    Bessa SS. Comparison of short-term results between the modified Karydakis flap and the modified Limberg flap in the management of pilonidal sinus disease: a randomized controlled study. Dis Colon Rectum. 2013;56(4):491–8. Scholar
  31. 31.
    Hull TL, Wu J. Pilonidal disease. Surg Clin North Am. 2002;82(6):1169–85. Scholar
  32. 32.
    Humphries AE, Duncan JE. Evaluation and management of pilonidal disease. Surg Clin North Am. 2010;90:113–24. Scholar
  33. 33.
    Käser SA, Zengaffinen R, Uhlmann M, Glaser C, Maurer CA. Primary wound closure with a Limberg flap vs. secondary wound healing after excision of a pilonidal sinus: a multicentre randomised controlled study. Int J Color Dis. 2015;30(1):97–103. Scholar
  34. 34.
    Kepenekci I, Demirkan A, Celasin H, Gecim IE. Unroofing and curettage for the treatment of acute and chronic pilonidal disease. World J Surg. 2010;34(1):153–7. Scholar
  35. 35.
    McCallum IJ, King PM, Bruce J. Healing by primary closure versus open healing after surgery for pilonidal sinus: systematic review and meta-analysis. BMJ. 2008;19:868–71. PubMed.CrossRefGoogle Scholar
  36. 36.
    Omer Y, Hayrettin D, Murat C, Mustafa Y, Evren D. Comparison of modified Limberg flap and modified elliptical rotation flap for pilonidal sinus surgery: a retrospective cohort study. Int J Surg. 2015;16:74–7. Scholar
  37. 37.
    Langan SM, Powell FC. Vegetative pyoderma gangrenosum: A report of two new cases and a review of the literature. Int J Dermatol. 2005;44(8):623–9. PMID 16101860.CrossRefGoogle Scholar
  38. 38.
    Rashid RM. Seat belt pyoderma gangrenosum: Minor pressure as a causative factor. J Eur Acad Dermatol Venereol. 2008;22(10):1273–4. PMID 18837131.CrossRefGoogle Scholar
  39. 39.
    Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. Br Med J. 2006;333(7560):181–4. PMC 1513476. PMID 16858047.CrossRefGoogle Scholar
  40. 40.
    Hemashettar BM, Siddaramappa B, Munjunathaswamy BS, et al. Phaeoacremonium krajdenii, a cause of white grain eumycetoma. J Clin Microbiol. 2006;44(12):4619–22. PMC 1698411. PMID 17005754.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Severo LC, Oliveira FM, Vettorato G, Londero AT. Mycetoma caused by Exophiala jeanselmei. Report of a case successfully treated with itraconazole and review of the literature. Rev Iberoam Micol. 1999;16(1):57–9. PMID 18473595.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Vilela R, Duarte OM, Rosa CA, et al. A case of eumycetoma due to Madurella grisea in northern Brazil (PDF). Mycopathologia. 2004;158(4):415–8. PMID 15630550.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Dorlands Medical Dictionary:botryomycosis. 2008. Archived from the original on 5 Sept 2008. Retrieved 10 July 2018.Google Scholar
  44. 44.
    Capoor MR, Khanna G, Nair D, et al. Eumycetoma pedis due to Exophiala jeanselmei. Indian J Med Microbiol. 2007;25(2):155–7. PMID 17582190.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Loulergue P, Hot A, Dannaoui E, et al. Successful treatment of black-grain mycetoma with voriconazole. Am J Trop Med Hyg. 2006;75(6):1106–7. PMID 17172376.CrossRefGoogle Scholar
  46. 46.
    Jiménez-Gallo D, Ossorio-García L, Linares-Barrios M. Calcinosis cutis and calciphylaxis. Actas Dermosifiliogr. 2015;106(10):785–94.CrossRefGoogle Scholar
  47. 47.
    Valenzuela A, Chung L. Calcinosis: pathophysiology and management. Curr Opin Rheumatol. 2015;27(6):542–8.CrossRefGoogle Scholar
  48. 48.
    Gunasekera NS, Maniar LEG, Lezcano C, Laga AC, Merola JF. Intralesional sodium thiosulfate treatment for calcinosis cutis in the setting of lupus panniculitis. JAMA Dermatol. 2017;153(9):944–5.CrossRefGoogle Scholar
  49. 49.
    García-García E, López-López R, Álvarez-Del-Vayo C, Bernabeu-Wittel J. Iatrogenic calcinosis cutis successfully treated with topical sodium thiosulfate. Pediatr Dermatol. 2017;34(3):356–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Vibhakar Vachhrajani
    • 1
  • Payal Khakhkhar
    • 1
  1. 1.Diabetic foot and wound managementVijay Vachhrajani Memorial Hospital RajkotIndia

Personalised recommendations